An immunosuppressive antimetabolite, mycophenolate mofetil (MMF), has been widely used in combination with a calcineurin inhibitor for organ transplantation and autoimmune diseases. Aˆxed dosing of MMF often causes bone marrow toxicity or cytomegalovirus antigenemia under the optimal dosing of calcineurin inhibitors. Pharmacokinetic characteristics of MMF and its relation to the degree of immune suppression have not been fully clariˆed in clinical practice. This review summarizes our achievements on pharmacokinetic disposition of mycophenolic acid (MPA) and inosine 5′ -monophosphate dehydrogenase (IMPDH) activity in patients with kidney transplantation and with lupus nephritis. Contribution of enterohepatic recirculation to plasma disposition of MPA in lupus nephritis patients was similar to that in tacrolimus-treated kidney transplant recipients. MPA pharmacokinetics in lupus nephritis was characterized by high MPA clearance most likely due to better renal function. In addition, concomitant metal cation decreased MPA concentration in patients receiving tacrolimus but not cyclosporine. This interaction may depend on amount of biliary-excreted MPA glucuronide. Renal clearance of MPA was higher in cyclosporine-than tacrolimus-treated patients. Its ratio to creatinine clearance was much higher than unbound fraction of MPA in each calcineurin inhibitor treatment. These kinetic data revealed the presence of renal tubular secretion in the urinary excretion process. In multivariate analysis, the plasma disposition of MPA and its glucuronides aŠected IMPDH activity in erythrocytes. The IMPDH activity might be a useful marker re‰ecting a long-term exposure by MPA. Ourˆndings in this review would contribute to optimal dosing of MMF in immunosuppressive regimen including a calcineurin inhibitor.
MPA, mycophenolic acid; MPAG, MPA phenolic glucuronide; AcMPAG, MPA acyl glucuronide; CyA, cyclosporine; IMPDH, inosine 5′ -monophosphate dehydrogenase; IMP, inosine 5′ -monophosphate; XMP, 5′ -xanthosine monophosphate; and GMP, 5′ -guanosine monophosphate. MMF の約 95％が MPAG となって尿中排泄され MPA はプリン生合成経路の 1 つである de novo and Acyl Glucuronide (AcMPAG) (C) and Inosine 5′ -monophosphate Dehydrogenase (IMPDH) Activity in Erythrocytes in Kidney Transplant Recipients IMPDH activity in erythrocytes (n＝6) from predose (dots) to 12 hours (arrows) after mycophenolate mofetil administration 30 days after transplantation is shown. Blood samples in 6 patients were drawn at predose (dots), 30 minutes, and 1, 2, 5, 8, and 12 (arrows) hours after morning drug administration 30 days after transplantation. 
